Veterans’ RightsAn independent resource for veterans
← All decisions
Remanded (sent back)

The Board has remanded the Veteran's claims for ischemic heart disease and prostate cancer due to potential herbicide exposure during service. The AOJ is instructed to verify the Veteran's assertions of exposure in Guam and at Westover Air Force Base.

The deciding factor: The Board found that the Veteran may have been exposed to herbicide agents, but the AOJ failed to properly develop this aspect of the claim.

Claimed conditions
ischemic heart disease, prostate cancer
How they argued it
Presumptive (no nexus needed)
Exposure basis
None
Rating assigned
None in this decision
Decision date
October 12, 2021
Citation
A21016550

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A21016550.

What this means for you

A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.